6640--Inhalation Exposure System 36C24726Q0168
Summary
AI-generated · Dec 17, 2025Procure the Buxco Inhalation Exposure System from Data Sciences International under a firm-fixed-price sole-source contract due to proprietary constraints that make only one source reasonably available. The system provides real-time respiration monitoring during exposure paired with real-time concentration data to produce live Accumulated Inhaled Aerosol (AIA).
Key features driving the requirement include SmartStudy for subject-specific dose targeting and multi-group exposures with improved safety from aerosol contamination, automated plethysmograph calibration, and software-controlled control of critical tower parameters (flows, pressures, relative humidity, etc.). Halcyon technology cancels atmospheric noise, and the Allay-restraint system secures animals without constriction, collectively delivering highly precise respiratory measurements, reduced animal use, and accurate deposition data. Capability statements from all responsible sources are invited; responses should reference the inhalation tower product in the subject line and are due by the stated deadline.
Special Notice Special Notice Page 3 of 3 This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs on behalf of the Charleston VA Medical Center intend to award a Firm Fixed Price (FFP), sole source action to a Small Businesses (SB). Name of Contractor: Data Sciences International, Inc Street Address: 119 14th ST NW STE 100 City, State, Zip: Saint Paul, MN 55122-3419 The objective of this action is to procure the Buxco Inhalation Exposure System manufactured by Data Sciences International. In accordance with FAR Part 13.106-1, it has been determined that only one source is reasonably available and therefore restricts this requirement to a brand name only procurement due to proprietary constraints. No other system provides the ability to perform accurate real-time respiration monitoring during exposure, integrated with real-time concentration values to produce live Accumulated Inhaled Aerosol (AIA). Furthermore, recently released SmartStudy, patent-pending, enables the closure of a single exposure port, allowing the user subject-specific delivered dose targeting, multiple dose-groups exposure, and user safety from aerosol contamination. These unique features only provided by DSI are critical for animal welfare, breathe morphology, reduction in animal use and determining accurate deposition levels. Also unique to DSI is automated plethysmograph calibration and software-controlled automation/regulation of critical inhalation tower parameters including all flows, pressures RH, and others. The DSI system utilizes patented Halcyon technology to cancel out atmospheric pressure noise, ensuring that air disturbances like slamming doors do not interfere with data accuracy. It also features the patented Allay-restraint system, which secures animals for dosing and measurement without physical constriction. Together, these innovations allow for highly precise respiratory measurements by eliminating both external artifacts and the physiological stress of traditional restraints. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on December 22, 2025. Responses to be submitted to Darius Crane, Contracting Officer at darius.crane@va.gov. Place in the subject line of your response 36C24726Q0168 INHALATION TOWER . A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
From Special Notice posted on Dec 16, 2025Notice history
1-
Special Notice LATEST Posted Dec 16, 2025
Details
Award Information
Contacts
Contracting Officer
Phone